Maria Alejandra Palacios-Ariza

Dr. Maria Alejandra Palacios-Ariza

Unidad de investigación, Fundación Universitaria Sanitas, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GCGiulio Corrivetti
Giulio Corrivetti
FMFrancesco Monaco
Francesco Monaco
AVAnnarita Vignapiano
Annarita Vignapiano
AMAlessandra Marenna
Alessandra Marenna
KPKaia Palm
Kaia Palm
Alessio FasanoAlessio Fasano
Alessio Fasano
According to the World Health Organization (WHO), major depressive disorder (MDD) is the fourth leading cause of disability worldwide and the second most common disease after cardiovascular events. Approximately 280 million people live with MDD, with incidence varying by age and gender (female to male ratio of approximately 2:1). Although a variety of antidepressants are available for the different forms of MDD, there is still a high degree of individual variability in response and tolerability. Given the complexity and clinical heterogeneity of these disorders, a shift from “canonical treatment” to personalized medicine with improved patient stratification is needed. OPADE is a non-profit study that researches biomarkers in MDD to tailor personalized drug treatments, integrating genetics, epigenetics, microbiome, immune response, and clinical data for analysis. A total of 350 patients between 14 and 50 years will be recruited in 6 Countries (Italy, Colombia, Spain, The Netherlands, Turkey) for 24 months. Real-time electroencephalogram (EEG) and patient cognitive assessment will be correlated with biological sample analysis. A patient empowerment tool will be deployed to ensure patient commitment and to translate patient stories into data. The resulting data will be used to train the artificial intelligence/machine learning (AI/ML) predictive tool.

5 August 2021 in Dermatology Reports
Verified
Journal Article
Open access
PDF file
LTLaura Trujillo-Ramirez
Laura Trujillo-Ramirez
Maria Alejandra Palacios-ArizaMaria Alejandra Palacios-Ariza
Maria Alejandra Palacios-Ariza
IPIvan Pradilla
Ivan Pradilla
LGLuis Arturo Gamboa
Luis Arturo Gamboa
Objective: To describe the neurological features of the physical examination in patients with Hansen’s disease who were treated in Bogotá, Colombia.Methods: We carried out a descriptive study of all patients with a Hansen’s disease diagnosis treated at a referral center between 2003-2018.Results: There were 327 eligible electronic health records (EHRs) with a final sample of 282 subjects. Leprosy was most common in males (57.45%), median age at the diagnosis was 54 years, and lesions of the lower limbs were more common (75.1%). The median time from disease onset to consult was 12 months. Most of them were classified as having lepromatous leprosy (39.7%). Pain over the median nerve trunk was the most common manifestation of disease (28%), followed by pain over the radial trunk (22%). Sensitive alterations were more common than motor ones. Specifically, the posterior tibial nerve was affected in nearly half of subjects. Dual impairment was more common in the ulnar nerve (13.8%). Some disability was apparent in 23.8% of subjects; predominantly grade 1 disability.Conclusion: Findings regarding age, leprosy type, and the frequency of individual nerve compromise were consistent with reports from other countries. Nerve trunk thickening was infrequent, which might be a consequence of subjectiveness in the examination and sample differences in sex distribution, degree of disability and time since disease onset. The frequency of morbidity and disability found in this sample, though low when compared with other series, fails to meet public health goals, including those limiting disability in younger subjects.

5 July 2023 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JCJhon Camacho-Cruz
Jhon Camacho-Cruz
Maria Alejandra Palacios-ArizaMaria Alejandra Palacios-Ariza
Maria Alejandra Palacios-Ariza
LOLuisa Orrego-Celestino
Luisa Orrego-Celestino
NVNatalia Valbuena-Velandia
Natalia Valbuena-Velandia
LPLaura Paez-Castellanos
Laura Paez-Castellanos
IPIván Pradilla
Iván Pradilla

21 December 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
Maria Alejandra Palacios-ArizaMaria Alejandra Palacios-Ariza
Maria Alejandra Palacios-Ariza
EMEsteban Morales-Mendoza
Esteban Morales-Mendoza
JMJossie Murcia
Jossie Murcia
RARafael Arias-Duarte
Rafael Arias-Duarte
GLGermán Lara-Castellanos
Germán Lara-Castellanos
JMJorge McDouall
Jorge McDouall
Introduction: Bipolar disorder (BD) is a chronically progressive mental condition, associated with a reduced quality of life and greater disability. Patient admissions are preventable events with a considerable impact on global functioning and social adjustment. While machine learning (ML) approaches have proven prediction ability in other diseases, little is known about their utility to predict patient admissions in this pathology.Aim: To develop prediction models for hospital admission/readmission within 5 years of diagnosis in patients with BD using ML techniques.Methods: The study utilized data from patients diagnosed with BD in a major healthcare organization in Colombia. Candidate predictors were selected from Electronic Health Records (EHRs) and included sociodemographic and clinical variables. ML algorithms, including Decision Trees, Random Forests, Logistic Regressions, and Support Vector Machines, were used to predict patient admission or readmission. Survival models, including a penalized Cox Model and Random Survival Forest, were used to predict time to admission and first readmission. Model performance was evaluated using accuracy, precision, recall, F1 score, area under the receiver operating characteristic curve (AUC) and concordance index.Results: The admission dataset included 2,726 BD patients, with 354 admissions, while the readmission dataset included 352 patients, with almost half being readmitted. The best-performing model for predicting admission was the Random Forest, with an accuracy score of 0.951 and an AUC of 0.98. The variables with the greatest predictive power in the Recursive Feature Elimination (RFE) importance analysis were the number of psychiatric emergency visits, the number of outpatient follow-up appointments and age. Survival models showed similar results, with the Random Survival Forest performing best, achieving an AUC of 0.95. However, the prediction models for patient readmission had poorer performance, with the Random Forest model being again the best performer but with an AUC below 0.70.Conclusion: ML models, particularly the Random Forest model, outperformed traditional statistical techniques for admission prediction. However, readmission prediction models had poorer performance. This study demonstrates the potential of ML techniques in improving prediction accuracy for BD patient admissions.

8 April 2024 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
IFIsabella Fakih‐Botero
Isabella Fakih‐Botero
MCMaria Camila Cerchiaro‐Mejia
Maria Camila Cerchiaro‐Mejia
MRMaria Juliana Rusinque
Maria Juliana Rusinque
Maria Alejandra Palacios-ArizaMaria Alejandra Palacios-Ariza
Maria Alejandra Palacios-Ariza
Clara Plata-GarciaClara Plata-Garcia
Clara Plata-Garcia
SPStephania Peña‐Hernández
Stephania Peña‐Hernández

23 April 2023 in Infectio
Verified
Journal Article
Open access
PDF file
IGIván Felipe Gutiérrez-Tobar
Iván Felipe Gutiérrez-Tobar
Maria Alejandra Palacios-ArizaMaria Alejandra Palacios-Ariza
Maria Alejandra Palacios-Ariza
DLDiego Andrés Luna-Solarte
Diego Andrés Luna-Solarte
WNWilliam Hernando Niño-Uribe
William Hernando Niño-Uribe
AGAngie Catalina González-Garzón
Angie Catalina González-Garzón
CÁCarlos Álvarez-Moreno
Carlos Álvarez-Moreno
En el año 2019 se publicó la guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia. Dicha guía excluía a la población pediátrica por sus consideraciones especiales. Teniendo en cuenta que estas infecciones representan un motivo de consulta frecuente en pediatría y que la emergencia del Staphylococcus aureus resistente a meticilina generan la necesidad de actualizar conocimientos y estrategias para el manejo de las infecciones de piel y tejidos blandos superficiales, se presenta esta guía de práctica clínica que da respuesta basada en la evidencia a 12 preguntas. Dicha evidencia fue adaptada y graduada bajo el sistema GRADE posterior a un proceso de adaptación de tres guías publicadas. Adicionalmente, se realizó una actualización de la evidencia científica bajo una búsqueda sistemática. Por último, se realizó un consenso de expertos para la evaluación de las potenciales barreras para la implementación de las recomendaciones en el contexto local.